Desirudin Subcutaneous and Lenvatinib Mesylate
Determining the interaction of Desirudin Subcutaneous and Lenvatinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: desirudin
Brand name: Iprivask
Synonyms: Desirudin
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Desirudin Subcutaneous-Lenvima
- Desirudin Subcutaneous-Lenvima (14 MG Daily Dose)
- Desirudin Subcutaneous-Lenvima (18 MG Daily Dose)
- Desirudin Subcutaneous-Lenvima (20 MG Daily Dose)
- Desirudin Subcutaneous-Lenvima (24 MG Daily Dose)
- Desirudin Subcutaneous-Lenvima (8 MG Daily Dose)
- Lenvatinib Mesylate-Desloratadine
- Lenvatinib Mesylate-Desloratadine and pseudoephedrine
- Lenvatinib Mesylate-Desloratadine Oral Solution
- Lenvatinib Mesylate-Desloratadine Orally Disintegrating Tablets
- Lenvatinib Mesylate-Desloratadine Syrup
- Lenvatinib Mesylate-Desloratadine Tablets